A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Parallel Group Multiple Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of PF-05089771 In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2011
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Jun 2011 New trial record